House Questions Health-Insurance Chiefs Over Premium Surges and Denials
TL;DR
In back-to-back House hearings, major health-insurance CEOs faced bipartisan grilling over rising premiums, prior-authorization rules, and claim denials, with lawmakers scrutinizing the role of PBMs and drug costs while insurers defend pricing as reflecting broader cost pressures in the system and subsidies remaining a political flashpoint.
Topics:nationpolicy#drug-pricing#health-insurance#healthcare-policy#pharmacy-benefit-managers#policy#premiums
- Health insurance CEOs grilled on high costs of care in back-to-back House hearings NBC News
- Big Insurers Try to Shift Blame for High Health Costs to Hospitals and Drug Makers The New York Times
- Congress grills health insurance CEOs over high pay Politico
- US health insurance executives testify before Congress about increasing costs of healthcare The Guardian
- Health Insurance CEOs Testify on Health Care Affordability C-SPAN
Want the full story? Read the original reporting
Read on NBC News